https://www.selleckchem.com/pr....oducts/fenretinide.h
39days, 95% CI 2.53-4.25; P 0.001) after ICU admission. Patients who received albumin combination at the first 24-h was associated with prolonged LOS in ICU (10.72days vs. 8.24days; P 0.001) but lower risk of 28-day mortality (12.5% vs 16.4%, P = 0.003) than those received crystalloids alone. In septic patients, receiving albumin combined within the first 24-h after crystalloids administration was associated with an increment of survival in 28 days. In septic patients, receiving albumin combined within the first 24-h after